The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)

CompletedOBSERVATIONAL

Enrollment

17,513

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Angiocardiography

Interventions

DRUG

Iopromide (Ultravist, BAY86-4877)

Intravenous/intraarterial digital subtraction angiography (DSA); Generally doses of up to 1.5 g iodine per kg body weight are well tolerated.

Trial Locations (1)

Many Locations